BackCSPC Pharmaceutical Group Limited. Overview

CSPC Pharmaceutical Group Limited. Minority Interest

CSPC Pharmaceutical Group Limited.'s minority interest is $1.8B.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$1.81B
11.99% YoYΔ $193.56M vs prior year quarter

Peer trimmed avg / median

Loading

CSPC Pharmaceutical Group Limited. Minority Interest History

Loading

CSPC Pharmaceutical Group Limited. vs. peers: Minority Interest Comparison

Loading

CSPC Pharmaceutical Group Limited. Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CSPC Pharmaceutical Group Limited. (CSPCY) FAQ

CSPC Pharmaceutical Group Limited. (CSPCY) currently reports a minority interest of $1.8B as of June 2026. That compares with $1.6B in the prior-year period — up 12.0% year over year. Use the charts on this page to explore CSPC Pharmaceutical Group Limited.'s minority interest history and peer comparisons.

CSPC Pharmaceutical Group Limited.'s minority interest increased from $1.6B to $1.8B — a 12.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CSPC Pharmaceutical Group Limited. reported $1.8B in minority interest as of June 2026. That compares with $1.6B in the prior-year period — up 12.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $1.8B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CSPC Pharmaceutical Group Limited., and consider following CSPCY for alerts when major investors trade the stock.

CSPC Pharmaceutical Group Limited. is classified in the Healthcare sector. On minority interest, it currently shows $1.8B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSPCY with unrelated industries.